GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human protective PROTEIN/CATHEPSIN a, dfp- inhibited (aged)

Analyse Crystal structure of human protective PROTEIN/CATHEPSIN a, dfp- inhibited (aged) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6WIA
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysosomal protective protein
EC
3.4.16.5
UniProt
P10619
Ligands
NAG, CD
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysosomal protective protein (EC 3.4.16.5)protein41134% helix, 22% strandP10619

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • CD · Cadmium ion · metal · 6 copies · chains A
  • ACT · Acetate ion · additive · 5 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14380.660.7857ACT
21590.610.8319ACT
3530.320.7716empty

Modifications

Observed in the structure: 4 disulfide, 2 glycan, 1 modified (disulfide, N-glycosylation, nonstandard).

Compared structures

  • 6WIA · Crystal structure of human protective PROTEIN/CATHEPSIN a, dfp-inhibited (aged) · the same entry in another collection · chain A against A, TM-score 1.00
  • P10619 · AlphaFold monomer V2.0 prediction for lysosomal protective protein (P10619) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.